Medtronic said that the U.S. District Court for the District of Delaware has reversed its prior summary judgment ruling finding that the company's S7 and Driver coronary stent products infringed one claim of Guidant's Lau patent.
Other decisions issued by the court on January 5 were unaffected by the ruling, according to Minneapolis-based Medtronic. A jury trial on Medtronic's claim that the Lau patents are invalid is expected to begin February 7. The trial will determine issues of infringement, as well as invalidity of the asserted Lau patents, Medtronic said.
By AuntMinnie.com staff writers
February 3, 2005
Related Reading
Court issues judgment in stent patent dispute, January 6, 2005
Medtronic receives FDA OK for stent clinical trial, February 12, 2004
Medtronic stent receives FDA OK, October 2, 2003
Butel named Medtronic VP, August 21, 2003
Medtronic starts multinational stent trials, July 17, 2003
Copyright © 2005 AuntMinnie.com
